Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 18303 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 58412 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 58699 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 59212 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 66178 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 66967 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 68830 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 69281 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 69361 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 69420 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 69795 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 69820 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 70738 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 73341 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 73372 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 74013 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 74186 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 76029 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 77105 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 77464 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 78471 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 79212 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 79380 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 79951 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 80061 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 80630 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 80920 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 81361 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 81602 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 81971 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 82382 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 82670 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 83148 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 83397 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 83602 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 84063 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 84407 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 84480 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 84557 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 87761 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 88566 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 88655 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 88835 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89025 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89486 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89488 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89580 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89708 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 89980 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 90201 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 90543 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 90762 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 90831 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 91841 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 93725 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 93761 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 93898 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 94060 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 94206 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 94323 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 94807 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 95854 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 95897 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 96811 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 96951 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 97037 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 97607 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 98463 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 98495 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 98654 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 99112 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 99217 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 100038 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 100328 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 100645 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 102102 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 102156 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 102222 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 103978 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 104508 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 104709 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 105361 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 105585 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 105828 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 105885 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 106276 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 106303 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 106668 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 106760 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 107053 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 107134 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 107231 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 107561 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 108039 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 108082 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 108123 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 109011 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 109011 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 110154 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 111477 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 111484 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 111724 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 112804 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 112820 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113004 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113036 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113581 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113679 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113709 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 113878 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114110 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114585 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114729 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114729 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114729 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 114873 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 115679 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 115696 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 115727 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 115763 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 116152 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 117027 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 117672 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 119920 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 120817 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 120845 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 121273 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 121369 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 121791 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 122005 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 122320 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 122476 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 122734 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 123668 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 123694 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 123758 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 123893 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 124841 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 125261 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 125611 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 125935 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 126674 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 126752 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 127056 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 127146 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 127504 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 128387 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 128650 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 128799 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 129512 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 129551 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 130328 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 130390 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 130672 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 132333 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 132937 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 133051 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 134469 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 135598 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 136360 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 136364 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 137903 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 139073 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 140452 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 140784 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 141359 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 141406 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 142329 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 142503 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 143410 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 143525 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 143534 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 147039 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 147780 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 148430 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 148655 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 148888 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 149118 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 149223 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 149789 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 150184 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 151439 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 153176 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 153266 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 154010 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 154671 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 155559 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 155654 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 156392 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 156926 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 157950 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 159179 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 159364 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 159788 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 160006 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 162216 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 164257 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 164749 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 164849 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (M-H)- | 166056 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Return to search page